-
2024-517553-26-00
5
2025-11-12
Advanced ALK-positive non-small cell lung cancer (NSCLC)
-
2024-519345-30-00
5
2025-11-12
IgA nephropathy
-
2024-519871-24-00
10
2025-11-11
Breast cancer
-
2025-520566-22-00
5
2025-11-10
Hormone Receptor-Positive, HER2-Negative Advanced/Metastatic Breast Ca
-
2023-509629-36-00
9
2025-10-29
Extensive-stage Small Cell Lung Cancer (ES-SCLC)
-
2024-519917-72-00
5
2025-10-29
Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amyloidosis with C
-
2024-516652-18-00
5
2025-10-10
Atherosclerotic cardiovascular disease (ASCVD) and obesity or overweig
-
2025-520535-16-00
6
2025-10-10
End-stage renal disease
-
2025-521147-21-00
4
2025-10-08
Lung Cancer
-
2024-514822-21-00
5
2025-10-02
Platinum-resistant Ovarian Cancer
-
2024-517671-21-00
5
2025-09-30
Coronavirus Disease 2019 (COVID-19)
-
2024-512177-27-01
5
2025-09-29
High-risk Bacillus Calmette-Guerin (BCG)-unresponsive non-muscle-invas
-
2024-518916-38-00
4
2025-09-29
knee synovitis and osteoarthritis
-
2024-516982-35-00
5
2025-09-11
Ovarian Cancer
-
2025-521152-34-00
4
2025-09-04
mantle cell lymphoma (MCL)
-
2025-520519-14-00
5
2025-09-03
Atherosclerotic Cardiovascular Disease
-
2024-519563-18-00
10
2025-09-02
Breast cancer, Ovarian cancer, Endometrial cancer
-
2023-508875-35-00
5
2025-09-01
Heart condition
-
2024-518154-16-00
5
2025-08-27
non-small cell lung cancer
-
2024-515561-34-01
6
2025-08-04
Acute ischemic stroke with recent ingestion of direct oral anticoagula
-
2024-519521-37-01
10
2025-07-30
Acute ischemic stroke
-
2024-520154-38-00
5
2025-07-29
Acute Myeloid Luekemia
-
2024-517727-39-00
5
2025-07-28
Covid-19 at high risk of progression to severe illness.
-
2025-521340-37-00
5
2025-07-24
small cell lung cancer